Medacta receives FDA clearance for shoulder placement guides
Click Here to Manage Email Alerts
Medacta announced receiving FDA clearance for their MyShoulder Placement Guides for shoulder arthroplasty.
“Medacta is dedicated to empowering surgeons through technology,” Francesco Siccardi, chief executive officer of Medacta International said in the release. “Our goal is to provide solutions that encourage surgeon input at all stages of the surgical process while providing patient-specific designs and insights to support them.”
The MyShoulder system is the first patient-specific technology in the United States. The 3D-printed solutions work alongside the Medacta Shoulder System and associated instrumentation to assist surgeons in creating an accurate and reproducible implant placement that is specific for each individual patient.
“Working with the MyShoulder Placement Guides enables me to play a key role in the surgical process from start to finish,” Matthew D. Saltzman, MD, associate professor of Orthopedic Surgery at the Northwestern Memorial Hospital in Chicago, Illinois said in the release. “Access to pre-operative planning and the support of a dedicated technician are key aspects of the platform and ensure the resulting guides are optimized for each procedure and patient.”
The MyShoulder Placement Guides will be added to Medacta’s Shoulder Learning Centers in the U.S.
Reference: